Prestige BioPharma Commences Construction of Innovative Discovery Center (IDC) in Busan, Korea

2021年12月21日 09:11:02 来自: (0)参与

SINGAPORE -- (BUSINESS WIRE) --

Prestige BioPharma Limited (PBP, 950210: KRX), a Singapore-based biopharmaceutical with operations in USA and South Korea, commences construction of Innovative Discovery Center (IDC) in Busan, South Korea. The construction of IDC is scheduled for completion by February 2023.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211219005014/en/

PBP holds a groundbreaking ceremony on December 21, 2021 with Korean government officials and guests including Deputy Mayor of Busan City Mr. Yoon-il Kim, Director General for Investment Policy of the Ministry of Trade, Industry and Energy Mr. Jong-young Jung and Head of Development Administration Division in Busan-Jinhae Free Economic Zone Authority (BJFEZ) Mr. Seokho Cha.

PBP is on target to build the global-scale R&D centre with a total area of approximately 34,000 square meters and facilities sufficient for 800 researchers. Earlier in May this year, PBP and Busan City Government had signed an MOU for the establishment of IDC in which the company’s plan to invest over US$200 million by 2030 was announced.

IDC will be focusing on diverse first-in-class antibody biologics discovery starting from 8 bispecific antibody projects based on PBP’s proprietary oncology therapeutic targets, PAUF and CTHRC1. Next generation vaccines using mRNA technologies and bioinformatics will be developed in IDC for current and potential future pandemics.

IDC also will be hiring more than 250 of PhD and highly qualified R&D personnel over the next five years and fifty percent of its R&D resources will be sourced from local universities and community.

As the first global scale R&D center in Busan, IDC is expected to lead the growth of Busan’s bioindustry and to lay a foundation to make the region into a viable bio-cluster that supports the local economy and drives mutual growth in academia and industry. IDC is planning to implement an open innovation platform that provides the local biomedical society a ‘one stop’ R&D solution for full cycle of new drug development targeting global markets.

PBP’s CEO, Dr Lisa S. Park commented: “IDC will be leading PBP Group’s innovative drug discovery R&D in connection with our research centers in Singapore and US and creating a global open innovation hub for industry-academic collaboration” and “we envision IDC where Prestige Biopharma’s innovation realizes and the start of a new world-class bio-cluster here in Busan”.

Hyeong-joon Park, Mayor of Busan City, commented: “We are very excited to have a global scale bio-R&D center in Busan and work with a global leading bio-pharmaceutical company, Prestige Biopharma. Busan City will fully support PBP’s IDC so this novel partnership can lead a local bio-industry’s growth and contribute to local economic development and high-quality job creation”.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211219005014/en/

CONTACT:

Media enquiries:
Global Communication Team
Prestige BioPharma Ltd.

Yujin Suh
Tel: +65-6924-6535
info@pbpsg.com
yujin.suh@prestigebio.com

PBP's Innovative Discovery Center (IDC) in Busan, Korea (Photo: Business Wire)

相关新闻
凤凰网友:迩卜Sんī涐旳谁
评论:法国有个圣女,叫贞德。中国有好多剩女,是真的。

搜狐网友:疲惫了放手了
评论:中国高中作业一年布置3亿多字,卷子连起来可绕地球5圈,连续8年销售数量第一!

本网网友:黒色曼陀罗
评论:何为女流氓?答曰:思想上的女流氓。生活上的好姑娘。外形上的柔情少女。心理上的变形金刚……

网易网友:离心   ■
评论:我伸出三根手指说:“送你五个字,一派胡言!“

天涯网友:基情无处不在
评论:赚钱像接露水那么辛苦,花钱却像流水那么迅速

百度网友:染尘 /9 Demon。
评论:没事的话别来找我,有事那就更别来找我了。

淘宝网友:-旧流年 seven ||
评论:爱由一个笑容开始,用一个吻来成长,用一滴眼泪来结束。

其它网友:错过的情人
评论:从小就有一个敌人叫“别人家的小孩”。他不爱玩游戏,从来只知道学习。

天猫网友:执念/173yeah°
评论:吃东西不代表饿了,只是因为嘴巴寂寞

猫扑网友:圈套  Easuysug▍
评论:据说两男一女走在街上,三人都会觉得自己是电灯泡。

新闻转自网络媒体,如有侵权,请与我们联系:1160322105@qq.com责编:admin